[S-22] Symposium 22「Historical and More Common Nongenetic Movement Disorders From Asia」

[S-22-1] 硬膜移植後Creutzfeldt-Jakob病と医原性脳アミロイドアンギオパチー

山田 正仁^1,2 (1.国家公務員共済組合連合会 九段坂病院, 2.東京医科歯科大学)

Dr. Masahito Yamada, MD, PhD, is currently the Director of Kudanzaka Hospital in Tokyo. He graduated from Tokyo Medical and Dental University School of Medicine in 1980, and had training in neurology, pathology, and neuroscience in Tokyo Medical and Dental University, its affiliated hospitals, and the University of California at San Diego. He was appointed to Associate Professor of Neurology at Tokyo Medical and Dental University in 1999, and to Professor and Chair in the Department of Neurology, Kanazawa University, Kanazawa, Japan, in 2000. In 2021, he moved to Kudanzaka Hospital. His clinical and research interest is in dementia and amyloid, including Alzheimer’s disease, cerebral amyloid angiopathy, and prion disease. He has been the Chair of Dementia Section in the Japanese Society of Neurology (JSN). He received the Japanese Society of Neuropathology (JSNP) Award, the Sugita Genpaku Award, the JSN Award, the Catalyst Award of the U.S. National Academy of Medicine (NAM), etc.